Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable

This article affects  the problems of using NOAC in the most defenseless groups  of patients with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus is on comparison of effectiveness and safety of NOACs based  on randomized clinical trials (RCT) an...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Stolichnaya Izdatelskaya Kompaniya 2018-11-01
Reeks:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Onderwerpen:
atrial fibrillation
difficult patients
elderly
rivaroxaban
warfarin
Online toegang:https://www.rpcardio.com/jour/article/view/1769
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items